Medable Inc.: Medable Selected by GSK to Power Decentralized and Hybrid Clinical Trials Across Global Product Portfolio
Medable Inc., the leading software provider for patient-centered clinical trials, today announced that it has entered a four-year enterprise contract with GSK to enable decentralized clinical trials
Source: finanznachrichten.de